Dr. Mahdi Fallah, MD, PhD, leads the Risk Adapted Prevention (RAD) Group within the Division of Primary Cancer Prevention. He holds a visiting professorship at the Department of Clinical Sciences, Lund University, Malmö, Sweden. Previously, he served as Professor of Medicine (Epidemiology) at the University of Bergen, Norway, and Adjunct Professor at the Institute of Primary Health Care (BIHAM), University of Bern, Switzerland. His research is dedicated to risk-adapted cancer prevention.
The Risk Adapted Prevention (RAD) Group focuses on identifying individuals at elevated risk for common cancers, including prostate, breast, and colorectal cancer, to optimize screening strategies for them. Their primary objective is to develop and validate robust risk-adapted models that determine the optimal starting age and screening interval for cancer screening. These models will incorporate a comprehensive range of individual risk factors, including family history of cancer, personal medical history, medication use, race/ethnicity, socioeconomic status, and other relevant factors. The disparities in cancer incidence and mortality across different racial and ethnic groups are acknowledged by incorporating factors that may disproportionately affect certain populations. By tailoring screening recommendations to specific patient populations, the RAD Group aims to significantly enhance cancer prevention and early detection in a risk-adapted (personalized), equitable, and cost-effective manner.
Research focus
- Risk-adapted cancer prevention
- Familial cancers
- Screening & Early detection
- Race/ethnicity and cancer equity (race-adapted cancer prevention)
- Colorectal cancer prevention
- Breast cancer prevention
- Prostate cancer prevention
Studies and projects (PI or co-PI):
- COCO: Extensive research linking over 60 diseases (comorbidities) with increased risk of colorectal cancer
PEARL: Prevention of early-onset colorectal cancer
- ACED: International Alliance for Cancer Early Detection
| Postdocs | PhD students | |
| Current members of RAD Group | Dr. Behzad Heibati |
|
Former members of RAD Group |
|
|
Publications
Selected publications from recent years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Press releases
- Maternal overweight as risk factor for childhood leukemia in daughters
- Repeated polyp diagnoses in relatives indicate higher risk of colorectal cancer
- 2024 Colonoscopy for early cancer detection: Longer interval between two examinations possible
- Age to initiate breast cancer screening should be adjusted for ethnicity
- Researchers recommend earlier start of breast cancer screening with family history of ovarian cancer
- Familial colorectal cancer: Underestimated risk for half-siblings
- Diabetes mellitus: A risk factor for early colorectal cancer
- From what age should relatives of patients with colorectal cancer start screening?
- World Diabetes Day: Preventing diabetes means preventing cancer
- Risikoadaptierte Empfehlungen: Alter für den Start des Brustkrebs-Screenings ist abhängig von der ethnischen Abstammung
- Prostatakrebs-Risiko: Die Rolle der Verwandten
- Familiärer Darmkrebs: Unterschätztes Risiko für Halbgeschwister
- Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
- Darmkrebsrisiko: Wann sollten familiär vorbelastete Personen mit der Früherkennung beginnen?
- Familiäres Brustkrebsrisiko: Ab wann ist eine Brustkrebsfrüherkennung sinnvoll?
- Registerbasierte Studien: Nordische Länder als Vorbild
- Weltdiabetestag: Diabetes vorbeugen heißt Krebs vorbeugen